Minimum Inhibitory Concentration (MIC) Determination by Broth Microdilution: A Practical Protocol

The minimum inhibitory concentration (MIC) is the lowest concentration of an antimicrobial agent that visibly inhibits the growth of a microorganism after overnight incubation. Broth microdilution is a quantitative, reference-standard method for MIC determination performed in 96-well microtiter plates, where serial two-fold dilutions of an antimicrobial are tested against a standardized bacterial inoculum. This method is essential for determining antimicrobial susceptibility profiles, detecting emerging resistance, and guiding therapeutic decisions in both clinical and research microbiology laboratories. It is particularly useful when precise quantitative MIC values are required, such as for monitoring resistance trends, evaluating new antimicrobial compounds, or confirming borderline susceptibility results obtained from other methods.

At a Glance

Scientific Principle of Broth Microdilution

The broth microdilution method relies on the principle that bacterial growth in liquid medium can be detected visually as turbidity or measured spectrophotometrically. When an antimicrobial agent is present at a concentration sufficient to inhibit bacterial multiplication, the medium remains clear. The MIC is defined as the lowest concentration of the antimicrobial that prevents visible growth of the test organism under standardized conditions.

The method uses a two-fold dilution series of the antimicrobial agent prepared in a liquid growth medium, typically Mueller-Hinton broth (MHB) for non-fastidious organisms. Each well receives a standardized bacterial inoculum, and after incubation, the wells are examined for growth. The dilution series ensures that the MIC falls within a defined range, allowing precise quantification of susceptibility.

The relationship between antimicrobial concentration and bacterial growth follows a sigmoidal dose-response curve. At concentrations below the MIC, bacterial growth proceeds normally. Near the MIC, growth is partially inhibited, and at concentrations at or above the MIC, growth is completely suppressed. The broth microdilution method captures this transition point with a resolution determined by the dilution factor (typically two-fold).

Materials and Instrumentation Choices

Antimicrobial Stock Solutions

Antimicrobial powders for MIC testing must be of known potency, preferably USP or equivalent reference standards. Stock solutions are prepared at concentrations 10–100 times higher than the highest test concentration, accounting for the subsequent dilution steps. The choice of solvent and diluent depends on the antimicrobial's solubility properties. Water-soluble compounds are dissolved in sterile distilled water or phosphate buffer (pH 6.0–8.0). Poorly soluble compounds may require organic solvents such as dimethyl sulfoxide (DMSO), ethanol, or methanol, but the final solvent concentration in test wells should not exceed 1% (v/v) to avoid growth inhibition.

Stock solutions should be sterilized by filtration through 0.22-μm membrane filters, dispensed into aliquots, and stored at −70°C or below. Repeated freeze-thaw cycles must be avoided. The stability of each antimicrobial under storage conditions should be verified against published data or determined experimentally.

Growth Medium

Mueller-Hinton broth (MHB) is the recommended medium for most bacterial species, as specified by CLSI and EUCAST guidelines. For fastidious organisms, supplemented media may be required: MHB with 2–5% lysed horse blood for Streptococcus spp., or cation-adjusted MHB (CAMHB) for improved reproducibility with aminoglycosides and tetracyclines. The medium must be prepared fresh or stored according to manufacturer instructions, and the pH should be verified at 7.2–7.4 at room temperature.

Cation concentrations in the medium significantly affect MIC results, particularly for aminoglycosides, tetracyclines, and polymyxins. CAMHB contains specified concentrations of calcium (20–25 mg/L) and magnesium (10–12.5 mg/L). Laboratories should use commercially prepared CAMHB or verify cation concentrations if preparing medium in-house.

Microtiter Plates

Sterile, polystyrene, 96-well U-bottom or flat-bottom plates are suitable. U-bottom plates facilitate visual reading of endpoints, while flat-bottom plates are preferred for spectrophotometric reading. The plate material should not bind antimicrobial agents significantly; polystyrene is generally acceptable, but some compounds may require tissue culture-treated plates to minimize binding.

Plates can be prepared in advance, sealed, and stored at −70°C for up to 6 months. However, repeated freezing and thawing must be avoided. Commercially prepared, pre-dosed plates are available for many antimicrobial agents and offer improved standardization.

Inoculum Preparation

The bacterial inoculum must be standardized to achieve a final concentration of approximately 5 × 10⁵ CFU/mL in each well. This is typically accomplished by preparing a bacterial suspension equivalent to a 0.5 McFarland standard (approximately 1–2 × 10⁸ CFU/mL for most bacteria) and then diluting 1:100 in broth. The 0.5 McFarland standard can be prepared using a turbidity meter or by visual comparison against a barium sulfate standard.

For accurate inoculum preparation, the bacterial suspension should be prepared from an overnight culture grown on non-selective agar. Colonies are suspended in sterile saline or broth, and the turbidity is adjusted. The suspension should be used within 15–30 minutes to avoid changes in viable count.

Incubation Equipment

A microbiological incubator capable of maintaining 35 ± 2°C is required. For most non-fastidious organisms, ambient air incubation is sufficient. Streptococcus spp. and other capnophilic organisms require 5% CO₂. The incubator should be monitored with a calibrated thermometer and temperature should be recorded daily.

Controls: Essential for Valid Results

Growth Control

Each plate must include a growth control well containing inoculum and broth without antimicrobial agent. This well confirms that the medium supports bacterial growth and that the inoculum is viable. Visible turbidity in the growth control well after incubation validates the test.

Sterility Control

A sterility control well containing broth only (no inoculum, no antimicrobial) confirms that the medium and plate are sterile. No turbidity should be observed after incubation. If turbidity appears, the test is invalid due to contamination.

Antimicrobial Quality Control Strains

Reference strains with known MIC values must be tested concurrently with each batch of MIC determinations. CLSI and EUCAST provide recommended quality control (QC) strains and acceptable MIC ranges for each antimicrobial agent. Common QC strains include:

• Staphylococcus aureus ATCC 29213
• Escherichia coli ATCC 25922
• Pseudomonas aeruginosa ATCC 27853
• Enterococcus faecalis ATCC 29212

The MIC for each QC strain must fall within the established acceptable range for the test to be valid. If QC results are out of range, the test must be repeated after troubleshooting potential causes (e.g., degraded antimicrobial, contaminated reagents, incorrect inoculum).

Solvent and Diluent Controls

When organic solvents are used to prepare antimicrobial stock solutions, a solvent control well should be included containing the highest final solvent concentration (typically 1% v/v) with inoculum. This control verifies that the solvent does not inhibit bacterial growth.

Conceptual Workflow

Step 1: Prepare Antimicrobial Dilution Series

Prepare a two-fold dilution series of the antimicrobial agent in broth at 2× the desired final concentration. For example, to test a range of 0.125–64 μg/mL, prepare dilutions from 0.25 to 128 μg/mL. The dilution series can be prepared in a separate 96-well plate or in tubes.

The dilution scheme follows a geometric progression: starting from the highest concentration, each subsequent dilution is half the previous concentration. For accurate dilutions, use calibrated pipettes and mix thoroughly between transfers. The volume transferred should be equal to the volume of diluent to maintain the two-fold relationship.

Step 2: Dispense Antimicrobial Dilutions

Add 100 μL of each 2× antimicrobial dilution to the corresponding wells of the test plate. Typically, columns 1–10 contain the dilution series from highest to lowest concentration. Column 11 is reserved for the growth control (100 μL of broth without antimicrobial), and column 12 for the sterility control (100 μL of broth).

Step 3: Prepare and Standardize Inoculum

Prepare a bacterial suspension equivalent to a 0.5 McFarland standard in sterile saline or broth. Dilute this suspension 1:100 in broth to achieve approximately 1 × 10⁶ CFU/mL. This dilution should be prepared immediately before inoculation and kept at room temperature.

Step 4: Inoculate the Plate

Add 100 μL of the diluted inoculum to each well except the sterility control well. The final inoculum concentration in each well is approximately 5 × 10⁵ CFU/mL. The sterility control well receives 100 μL of sterile broth instead.

The inoculation should be completed within 30 minutes of preparing the diluted inoculum to maintain consistent viable counts. Use a multichannel pipette for efficiency, but change tips between rows to avoid cross-contamination.

Step 5: Incubate

Cover the plate with a sterile lid or seal with an adhesive plate sealer. Incubate at 35 ± 2°C for 16–20 hours in ambient air or 5% CO₂ as appropriate. Do not stack plates more than four high to ensure uniform temperature distribution.

Step 6: Read and Record Results

After incubation, examine each well for visible growth. The MIC is the lowest concentration of antimicrobial that completely inhibits visible growth. Record the MIC value in μg/mL.

For visual reading, hold the plate against a black background with indirect lighting. A growth button or pellet at the bottom of the well indicates bacterial growth. The absence of a pellet or turbidity indicates inhibition. For spectrophotometric reading, measure absorbance at 600 nm and define the MIC as the lowest concentration with absorbance less than 0.1 (or a defined threshold relative to the growth control).

Quality Checks and Validation

Inoculum Verification

Periodically verify the inoculum concentration by performing viable counts. Plate 10 μL of the diluted inoculum onto a non-selective agar plate, incubate overnight, and count colonies. The target count is 50–100 CFU per 10 μL, corresponding to 5 × 10⁵ CFU/mL in the inoculum.

Plate Uniformity

Inspect plates for air bubbles, uneven filling, or evaporation. Air bubbles can be removed by gentle tapping or brief centrifugation. Evaporation is minimized by using sealed plates and maintaining high humidity in the incubator.

Replicate Testing

For research applications, perform MIC determinations in duplicate or triplicate. The MIC should be reproducible within one two-fold dilution. If results vary by more than one dilution, investigate potential sources of variability.

Internal Quality Control

Implement an internal quality control (IQC) program using reference strains with known MIC values. As described by Fischer et al. [1], an integrated IQC panel can monitor all aspects of antimicrobial susceptibility testing, including broth microdilution. The IQC panel should be tested at regular intervals (e.g., weekly or with each batch) and results recorded in a quality control log.

Result Interpretation

Reading the MIC Endpoint

The MIC endpoint is the lowest concentration of antimicrobial that completely inhibits visible growth. For most antimicrobials, this is read as the first well in the dilution series that shows no turbidity, no pellet, and no visible growth.

Some antimicrobials exhibit trailing growth, where partial inhibition occurs over several dilutions. In such cases, the MIC is read at the first well where growth is completely suppressed. For bacteriostatic agents, a faint haze may be present at the MIC; this is considered acceptable if the growth control shows dense turbidity.

Interpreting MIC Values

MIC values are interpreted using clinical breakpoints established by CLSI or EUCAST. Breakpoints categorize organisms as susceptible (S), intermediate (I), or resistant (R) based on pharmacokinetic/pharmacodynamic data and clinical outcomes. For research purposes, MIC values may be compared to epidemiological cutoff values (ECOFFs) to distinguish wild-type from non-wild-type populations.

Recording Results

Record the MIC value in μg/mL, along with the interpretation (S, I, R) if clinical breakpoints are applied. Include the test date, organism identification, antimicrobial agent, and QC results. Use a standardized reporting format to facilitate data analysis and comparison.

Troubleshooting

Limitations

Method-Specific Limitations

Broth microdilution is labor-intensive when testing single isolates against multiple antimicrobials. The two-fold dilution series provides limited resolution; the true MIC may fall between tested concentrations. Some antimicrobials bind to plastic, reducing effective concentrations. The method requires overnight incubation, delaying results for clinical decision-making.

Organism-Specific Limitations

Fastidious organisms may require supplemented media or extended incubation. Slow-growing organisms may not produce visible turbidity within 16–20 hours. Some organisms form biofilms or clumps that interfere with endpoint reading. Anaerobic organisms require specialized handling and incubation conditions.

Antimicrobial-Specific Limitations

Polymyxins (colistin, polymyxin B) require the addition of polysorbate 80 to prevent binding to plastic. As noted by Shiromani et al. [5], broth microdilution is the gold standard for colistin susceptibility testing, but it requires careful attention to medium composition and endpoint reading. Essential oils and other hydrophobic compounds require emulsifiers such as Tween 80 for proper dispersion [2].

Interpretation Limitations

Clinical breakpoints may not apply to all organisms or antimicrobial combinations. MIC values alone do not predict clinical outcome; pharmacokinetic/pharmacodynamic parameters must be considered. The method does not distinguish between bactericidal and bacteriostatic activity.

Documentation and Reporting

Laboratory Records

Maintain detailed records of each MIC determination, including:

• Organism identification and source
• Antimicrobial agent, lot number, and expiration date
• Medium type, lot number, and preparation date
• Inoculum preparation method and verification results
• Incubation conditions (temperature, atmosphere, duration)
• QC strain results and acceptable ranges
• MIC values for test organism and interpretation
• Any deviations from standard protocol

Data Management

Use a laboratory information management system (LIMS) or spreadsheet to record and analyze MIC data. Include fields for organism, antimicrobial, MIC value, interpretation, QC results, and test date. For research studies, record additional metadata such as isolate source, collection date, and patient demographics.

Reporting Results

For clinical reporting, follow institutional guidelines for reporting MIC values and interpretations. Include the method used (broth microdilution) and the reference standard (CLSI or EUCAST). For research publications, report MIC values as geometric means or modal values with ranges, and include QC results.

Biosafety Considerations

Risk Assessment

Broth microdilution testing of non-pathogenic organisms (e.g., QC strains, environmental isolates) can be performed at BSL-1. Clinical isolates, particularly those from human sources, should be handled at BSL-2 following standard precautions. As outlined in the CDC/NIH BMBL 6th Edition [6], risk assessment should consider the organism's pathogenicity, route of transmission, and infectious dose.

Personal Protective Equipment

Wear a laboratory coat, gloves, and eye protection when handling bacterial cultures. Use a biosafety cabinet for procedures that may generate aerosols, such as vortexing or pipetting concentrated bacterial suspensions.

Decontamination and Waste Disposal

Decontaminate all used plates and materials by autoclaving before disposal. Treat liquid waste with appropriate disinfectant (e.g., 10% bleach) before disposal. Follow institutional guidelines for biohazardous waste management.

Recombinant or Synthetic Nucleic Acids

If the test organism contains recombinant or synthetic nucleic acid molecules, follow the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules [7] for appropriate containment and approval.

Frequently Asked Questions

1. How do I choose the concentration range for my MIC test?

The concentration range should span the expected MIC for the organism-antimicrobial combination. For clinical isolates, use ranges that include the clinical breakpoints. For research purposes, start with a broad range (e.g., 0.125–64 μg/mL) and narrow based on preliminary results. Consult published MIC distributions for the organism and antimicrobial of interest.

2. Can I use frozen pre-dosed plates for MIC testing?

Yes, pre-dosed plates can be stored at −70°C for up to 6 months. However, each freeze-thaw cycle may degrade the antimicrobial. Use plates within one hour of thawing and do not refreeze. Verify QC results with each batch of frozen plates.

3. How do I read MIC endpoints for antimicrobials that show trailing growth?

For trailing growth, read the MIC at the first well where growth is completely inhibited. Some guidelines recommend reading at 80% inhibition compared to the growth control. Consult CLSI or EUCAST guidelines for specific antimicrobial-organism combinations. For research purposes, clearly define the endpoint reading method in your protocol.

4. What should I do if my QC strain MIC is out of range?

First, verify that the QC strain is correct and uncontaminated. Check the antimicrobial stock solution for degradation (expiration date, storage conditions). Repeat the test with fresh antimicrobial stock and fresh medium. If the problem persists, contact the manufacturer of the antimicrobial or medium. Document all out-of-range results and corrective actions.

References and Further Reading

1. Fischer A, Cherkaoui A, Schorderet D, Wagner J, Schrenzel J. Total laboratory automation-based monitoring processes: setup and validation of an integrated internal quality control panel. 2026. PubMed ID: 42170675. [Describes an integrated IQC panel for monitoring broth microdilution and other AST processes in automated laboratories.]

2. Di Vito M, Mariotti M, Di Mercurio M, et al. Protocol for determining minimum inhibitory concentrations of essential oils against bacterial pathogens using broth microdilution. 2026. PubMed ID: 42166333. [Provides a detailed protocol for MIC determination of hydrophobic compounds using broth microdilution with emulsifiers.]

3. Moawad MA, Abd El-Aziz AM, Shaaban MI. In vitro and in vivo synergistic effects of cyclizine and piroxicam in combination with linezolid against methicillin-resistant Staphylococcus aureus. 2026. PubMed ID: 41857365. [Demonstrates use of broth microdilution and checkerboard methods for synergy testing.]

4. Ramezani A, Etezadi T, Goli H, et al. Comparison of the Antimicrobial Effect of Atorvastatin and Nano-Atorvastatin Mouthwash on Aggregatibacter Actinomycetemcomitans: An in vitro Study. 2026. PubMed ID: 42253832. [Illustrates microbroth dilution testing for antimicrobial activity assessment.]

5. Shiromani D, Ranjan N, Argal D. Estimation of Colistin Resistance Among Multidrug-Resistant Gram-Negative Bacilli: An Observational Study. 2026. PubMed ID: 42261523. [Validates broth microdilution as gold standard for colistin susceptibility testing.]

6. CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. U.S. Department of Health and Human Services, 2020. Available at: https://www.cdc.gov/labs/bmbl/index.html. [Authoritative biosafety guidelines for microbiological laboratories.]

7. National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. Available at: https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules/. [Framework for biosafety in recombinant nucleic acid research.]

8. National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. Available at: https://www.ncbi.nlm.nih.gov/books/. [Searchable collection of authoritative biomedical methods references.]

Related Articles

• How to Perform a Broth Microdilution MIC Test: Protocol and Endpoint Reading
• How to Perform an Etest for MIC Determination: Protocol and Interpretation
• How to Read and Interpret an Etest Strip for MIC Determination
• Etest for MIC Determination: How to Read and Interpret Results Accurately
• Comparison of Disk Diffusion and Broth Microdilution for Antimicrobial Susceptibility Testing
• Understanding CLSI Breakpoints for Disk Diffusion and MIC Interpretation